- Report
- April 2020
Europe
From €8551EUR$8,995USD£7,184GBP
- Report
- August 2024
- 83 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- July 2023
- 99 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- March 2022
- 81 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- December 2023
- 10 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2022
- 9 Pages
Global
From €2995EUR$3,150USD£2,516GBP
- Report
- February 2023
- 248 Pages
Global
From €3394EUR$3,570USD£2,851GBP
- Report
- October 2022
- 282 Pages
Global
From €3394EUR$3,570USD£2,851GBP
The Embolization Devices market within the Cardiovascular Devices sector is a specialized segment of the medical device industry. It includes a range of products used to treat a variety of conditions, including aneurysms, arteriovenous malformations, and other vascular diseases. These devices are designed to block or reduce the flow of blood to a specific area of the body, typically by using a catheter to deliver a small device, such as a coil, plug, or other embolic material. The embolic material is designed to occlude the vessel, preventing further blood flow.
The Embolization Devices market is a rapidly growing segment of the Cardiovascular Devices sector, driven by advances in technology and the increasing prevalence of vascular diseases. This market is expected to continue to grow in the coming years, as new products are developed and the demand for minimally invasive treatments increases.
Some of the major companies in the Embolization Devices market include Boston Scientific, Medtronic, Cook Medical, Terumo, and Merit Medical. Show Less Read more